November 2017

Cannabis could help treat the symptoms of Parkinson’s disease, according to a new study published in the journal Clinical Neuropharmacology. Researchers at Tel Aviv University in Israel assessed daily cannabis use in 47 Parkinson’s patients over several months. A grand majority – 82 percent – said cannabis “improved their overall symptoms.” These patients experienced reductions […]

by

CannPal Animal Therapeutics Ltd (ASX:CP1) has been granted an authorisation to possess and supply cannabis for scientific research by the New South Wales Ministry of Health. The authorisation has been issued under the provisions of the Drug Misuse and Trafficking Act 1985. Importantly, the permit allows CannPal to apply for permits to import cannabis for […]

by

The Canadian Securities Exchange (“CSE“) recently announced the introduction of the CSE25 Index, comprised of the securities of the largest companies trading on the exchange. The CSE25 Index is a subgroup of the CSE Composite Index. The composite index launched in 2015 and includes almost half of the exchange’s listed companies and, according to the […]

by

CAPITOLA, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) — A new study to understand the potential impact of cut-flower agribusiness land usage with the January 2018 legalization of cannabis production in California concludes there is no evidence it will affect the state’s ability to produce nearly 80 percent of the nation’s cut flower production. The study […]

by

VANCOUVER, Oct. 31, 2017 /CNW/ – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), is pleased to announce the signing of a Memorandum of Understanding (“MOU“) with the Bill Nelems Pain and Research Centre, operating the Okanagan Interventional Pain Clinic, to form a strategic alliance for the purpose of conducting clinical research and development of […]

by

Las Vegas, NV, Nov. 01, 2017 (GLOBE NEWSWIRE) — GB Sciences, Inc. (OTCQB: GBLX) inducts a Scientific Advisory Board to provide oversight for product development within GB Sciences’ intellectual property portfolio, consisting of three original patent applications, one licensed patent application, and one licensed approved patent. GB Sciences remains committed to discovering novel cannabis-based therapies […]

by

By Kema Ogden Wednesday, Nov. 1, 2017 | 2 a.m. A recent study co-funded by ESPN and the National Institute on Drug Abuse found that 52 percent of retired football players had used prescription pain drugs (opioids) during their professional careers. Of those, 63 percent admitted they received the painkillers from coaches, trainers, fellow teammates […]

by